| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |